In most cell types constitutive and ligand-induced apoptosis is a caspase-dependent process. In neutrophils however the broad-spectrum caspase inhibitor z-VAD-fmk enhances TNFα-induced cell death and this has been interpreted as evidence for caspasedependent and -independent cell death pathways. Our aim was to determine the specificity of the effect of z-VAD-fmk in neutrophils and define the potential mechanism of action. While confirming that z-VAD-fmk (>100µM) enhances TNFα-induced neutrophil apoptosis, lower concentrations (1-30µM) completely blocked TNFα-stimulated apoptosis. Boc-D-fmk, a similar broad-spectrum caspase inhibitor and z-IETD-fmk, a selective caspase-8 inhibitor caused a concentration-dependent inhibition only of TNFα-stimulated apoptosis. Moreover, the caspase-9 inhibitor, Ac-LEHD-cmk, had no effect on TNFα-induced apoptosis and z-VAD-fmk and Boc-D-fmk inhibited TNFα-stimulated ROS generation. These data suggest that TNFα-induced apoptosis in neutrophils is fully caspase-dependent, utilises a mitochondrial independent pathway and that the pro-apoptotic effects of z-VAD-fmk are compound specific and ROS independent.
INTRODUCTION
Tumour necrosis factor-α (TNFα)-stimulated killing of human neutrophils remains an ill defined event. This process may however play an essential role in the resolution of granulocytic inflammation since TNFα is abundantly expressed in acute inflammation and one of a small number of biological agents shown capable of stimulating neutrophil apoptosis. 1; 2 Recent studies have suggested that TNFα can induce cell death in neutrophils via distinct caspase-dependent and -independent pathways. This conclusion was based on the finding that high concentrations of z-VAD-fmk, a widely used broad-spectrum caspase inhibitor, enhance rather than inhibit TNFα-induced apoptosis.
3; 4 The cell death induced by the combination of z-VAD-fmk and TNFα lacked the usual nuclear features of apoptosis and was dependent on mitochondrial ROS generation. 4 While, the importance of caspase activation in constitutive and TNFα-stimulated apoptosis remains controversial, this result challenges the findings of a number of previous studies. 1 Moreover, despite evidence suggesting that caspases are activated when neutrophils undergo apoptosis, 5 we and others have been unable to demonstrate inhibition of constitutive apoptosis with either z-VAD-fmk or selective caspase-8 and 9 inhibitors z-IETD-fmk and Ac-LEHDcmk. 6;7 These data cannot be explained by a lack of cell permeability as these compounds inhibit the relevant caspase activity in intact cells and abolish Fas-L and gliotoxin-induced neutrophil apoptosis.
1; 4
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METHODS

Neutrophil isolation and culture
Neutrophils were purified from healthy donors and cultured in DMEM containing 10% autologous serum. 
Assessment of apoptosis
Apoptosis was assessed using Annexin-V-FITC (BD Biosciences, Oxford, UK) as previously detailed. 9 Our earlier studies have shown a tight correlation between this index of apoptosis and that determined by light or electron microscopy. 
Statistical analysis
Data are presented as mean ± SEM and analysed using a Student's t-test or ANOVA.
Values of p<0.05 were considered significant.
For
RESULTS and DISCUSSION
Effects of z-VAD-fmk on TNFα-mediated neutrophil apoptosis
z-VAD-fmk caused a biphasic effect on TNFα-stimulated neutrophil apoptosis. Hence, while z-VAD-fmk at or above 100µM enhanced the extent of apoptosis with TNFα, this compound caused full inhibition at lower concentrations (Figure 1a) (IC 50 0.7µM) .
Moreover, the effect of the higher concentrations of z-VAD-fmk on TNFα-mediated neutrophil killing appeared to be compound specific since Boc-D-fmk, an alternative broad-spectrum caspase inhibitor, and z-IETD-fmk, a caspase-8 inhibitor, caused full inhibition only of the pro-apoptotic effect of TNFα (Figure 1b-c) with IC 50 values of 39µM and 0.46µM respectively. These data re-establish caspases as essential in TNFα-induced apoptosis in neutrophils and suggest that the ability of z-VAD-fmk to enhance TNFα-induced killing is inhibitor specific and observed only at supra-physiological concentrations. This conclusion is supported by the distinct apoptotic/necrotic cell morphology observed in TNFα and z-VAD-fmk treated cells. 
Effects of z-VAD-fmk on TNFRI/II expression and TNFα-mediated NF-κB stimulation
We, and others have shown that inhibition of NF-κB causes a major potentiation of the pro-apoptotic effect of TNFα. 
z-VAD-fmk does not enhance TNFα-induced ROS production
Recent studies have suggested that while z-VAD-fmk can still enhance TNFα-stimulated apoptosis in patients lacking a functional NADPH oxidase, this effect is not seen in mitochondrial-deficient neutrophil cytoplasts. 3 Moreover, the augmentation of apoptosis by z-VAD-fmk could be inhibited by ROS scavengers and mitochondrial inhibitors suggesting that the cytotoxic effect of z-VAD-fmk is ROS-dependent. To explore this, we performed detailed kinetic analysis of the effects of z-VAD-fmk on TNFα-stimulated ROS generation using lucigenin and luminol. As shown in Figure 2a The involvement of a mitochondrial-dependent pathway in TNFα and TNFα/z-VADfmk-induced neutrophil apoptosis is further undermined by the inability of the highly effective caspase-9 inhibitor Ac-LEHD-cmk to inhibit TNFα or TNFα/z-VAD-fmkinduced cell death (Figure 1d ).
In summary, these data indicate that TNFα-induced apoptosis in human neutrophils is fully inhibited by a range of casapase inhibitors including z-VAD-fmk and do not support the view that TNFα uses a caspase-independent pathway. The augmentation of the TNFα-induced killing effect previously reported with z-VAD-fmk may represent a nonphysiological cytotoxic effect of this agent. 
